Quantcast

Latest Xenical Stories

2010-05-26 11:35:00

SILVER SPRING, Md., May 26 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today advised consumers and health care professionals about potential rare occurrences of severe liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and Alli. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) The FDA has approved a revised label for the prescription drug Xenical. The agency is working with the manufacturer of Alli on label...

2009-09-10 09:17:00

NEW YORK, Sept. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. World Anti-Obesity Drugs Market http://www.reportlinker.com/p0109903/World-Anti-Obesity-Drugs-Market.html This report analyzes the worldwide markets for Anti-Obesity Drugs in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2005 through...

2009-08-25 08:00:30

The U.S. Food and Drug Administration says it is reviewing reports of liver injury in patients taking the weight loss drug orlistat. From 1999 to 2008, the FDA received 32 reports of serious liver injury in patients taking orlistat, which is marketed as the prescription drug Xenical and the over-the-counter medication Alli. Of those cases, 27 reported hospitalization and six resulted in liver failure, the federal agency said. Thirty of the adverse events occurred outside the United States....

70ed7ffd8057f79a69a4d5e0249cd7f71
2009-02-25 06:40:00

A new study suggests that many people taking the weight-loss drug orlistat, sold under the prescription name Xenical, do not maintain the necessary dietary changes for the treatment's success. Orlistat aids weight loss by blocking the intestinal absorption of dietary fat. Those taking the drug are advised to limit their fat intake to less than 30 percent of their daily calories because higher amounts increase the risk of gastrointestinal side effects such as incontinence and loose stools....

2006-04-10 23:16:43

By Susan Heavey WASHINGTON (Reuters) - Roche Holding AG's prescription diet drug Xenical should immediately be pulled from the U.S. market after recent data linked it to precancerous colon lesions in animal studies, a consumer group told federal health regulators on Monday. In a petition, Public Citizen also asked the U.S. Food and Drug Administration to reject making the weight-loss pill widely available over the counter. On Friday, the FDA said it granted GlaxoSmithKline Plc....

2006-04-10 13:40:00

By Susan Heavey WASHINGTON -- Roche Holding AG's prescription diet drug Xenical should immediately be pulled from the U.S. market after recent data linked it to precancerous colon lesions in animal studies, a consumer group told federal health regulators on Monday. Public Citizen, in a petition, also asked the U.S. Food and Drug Administration to reject making the weight-loss pill widely available over the counter. On Friday, the FDA said it granted GlaxoSmithKline Plc conditional approval to...

2006-04-07 18:42:22

WASHINGTON (Reuters) - GlaxoSmithKline has received conditional approval for over-the-counter sales of the weight-loss drug Xenical, a U.S. Food and Drug Administration spokeswoman said on Friday. The British drugmaker received a letter from the FDA on Thursday for the drug, which would be sold under the brand name Alli, FDA spokeswoman Laura Alvey said. She did not say what steps the company must take before it can win final approval. Glaxo bought U.S. rights for nonprescription...

2006-01-23 20:28:35

By Susan Heavey BETHESDA, Maryland (Reuters) - The first diet drug aimed at helping the growing number of fat Americans lose weight without seeing a doctor moved one step closer to U.S. approval on Monday after a health advisory panel endorsed the idea. Called Alli, GlaxoSmithKline's low-dose version of the prescription drug Xenical is generally safe and effective for adults when used for six months, the U.S. Food and Drug Administration's advisers said. The FDA will consider the...

2006-01-23 19:20:33

By Susan Heavey BETHESDA, Maryland (Reuters) - A GlaxoSmithKline weight-loss drug should be approved for over-the-counter sales to help the growing number of obese and overweight Americans shed pounds, a U.S. advisory panel said on Monday. The U.S. Food and Drug Administration will consider the panel's advice as it decides whether to allow easier access to a low-dose version of the prescription drug Xenical. The FDA will weigh the panel's 11-3 vote to support the drug before making...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related